Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
Completed recruitment and randomization of all patients in the primary cohort of Phase IIb HbA1c trial for oral insulin capsule ORMD-0801, potentially the first commercial oral insulin capsule for the treatment of Type 2 diabetes; results expected in 4Q 2019; following results Oramed plans to initiate end of Phase II meeting with FDA to plan […]
